Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,705 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07470073RecruitingEarly Phase 1
Universal CAR-T cell therapy for B-cell leukemia (ages 12-75)
This trial tests a new type of CAR-T cell therapy (called universal CAR-T) that targets CD19 and CD20 markers on cancer cells. It is for people aged 12 to 75 with B-cell acute lymphoblastic leukemia that has not responded to standard treatments or has come back after treatment.
Wuhan, HubeiAges 12–75 - NCT06037564Enrolling by invitationPhase 4
Switching HIV treatment to a simpler daily pill
This study tests whether switching your current HIV medication to a daily pill with doravirine, dolutegravir, and lamivudine is safe and effective. It is for people whose HIV is well-controlled but who have had to change treatment before because it stopped working.
Aarau, Canton of AargauAges 18 years+ - NCT07110246RecruitingPhase 2
Dabrafenib and trametinib for BRAF-mutated low-grade gliomas
This trial tests two targeted drugs (dabrafenib and trametinib) for children and young adults with a specific type of low-grade brain tumor that has a BRAF V600 mutation. The drugs work by blocking signals that help the tumor grow.
Birmingham, AlabamaAges 1–25 - NCT06460519Recruiting
Comparing wrist and groin blood pressure in shock patients
This study looks at how blood pressure readings differ between the wrist and the groin in people with severe low blood pressure (shock) who are not recovering from heart surgery. It aims to help doctors better understand and treat shock by comparing these two measurements.
BronAges 18–99 - NCT06624904RecruitingEarly Phase 1
Losartan and social processing study
This study tests whether a blood pressure medication called losartan can affect how people process social situations. It may help researchers understand social behavior better.
Oxford, OxfordshireAges 18–50 - NCT04428554RecruitingPhase 2
Radiation to control bladder cancer spread after no growth
This trial tests whether giving focused radiation (SBRT) to a few remaining metastatic spots can stop bladder cancer from progressing after initial chemotherapy or immunotherapy has worked. It may help patients who still have up to three remaining distant lesions but are not getting worse.
AlbiAges 18 years+ - NCT06959108RecruitingPhase 2
Comparing two treatments for head and neck cancer before chemoradiation
This trial tests two different drug combos—one using an EGFR-targeted therapy alone, the other adding an immunotherapy—before standard chemoradiation for locally advanced head and neck cancer. The goal is to see which approach works better without prior treatment.
VillejuifAges 18–75 - NCT07441707RecruitingPhase 1
Tovorafenib for Japanese children and young adults with brain tumors
This study tests an experimental medicine called tovorafenib for children and young adults (6 months to 25 years) with Japanese ancestry whose low-grade brain tumors have returned or grown after prior treatment. The medicine targets tumors with a specific BRAF genetic change.
KanagawaAges 6 months–25 years - NCT06643403Recruiting
How aging affects oxygen use in the eyes of healthy people
This study looks at how the eyes use oxygen as people get older. It involves healthy volunteers between 18 and 80 years old who do not smoke, to see how their retinas process oxygen.
Vienna, State of ViennaAges 18–80 - NCT06446362Recruiting
Breastfeeding support for first-time mothers
This study tests whether personalized breastfeeding support helps first-time mothers feel more confident and have fewer problems. If you are in your last weeks of pregnancy, you may be able to join.
Denizli, PamukkaleAges 15–35 - NCT06985394Recruiting
Blood vessel health and stress in emergency responders
This study looks at how shift work affects blood vessel function and oxidative stress in emergency medical responders. It may help understand why first responders have higher risk for heart problems.
Newark, DelawareAges 20–40 - NCT07019818RecruitingPhase 4
Esmolol vs. sufentanil for recovery after gallbladder surgery
This trial tests two different medicines given during gallbladder surgery to see which one helps you recover better. One medicine (esmolol) controls heart rate, while the other (sufentanil) is a strong painkiller. The goal is to find out which approach leads to a smoother recovery after your surgery.
Brive-la-Gaillarde, FranceAges 18 years+ - NCT06640725RecruitingPhase 2
TPEx chemo with maintenance immunotherapy for advanced head and neck cancer
This trial tests a combination of chemotherapy drugs (TPEx) followed by two immunotherapy drugs (avelumab and cetuximab) as a first treatment for head and neck cancer that has spread or come back. It is for people whose tumors show a protein called PD-L1 and who have not had chemotherapy for advanced disease before.
Vandœuvre-lès-NancyAges 18–74 - NCT06450171Recruiting
Multi-cancer early detection test for people at high risk
This study tests a blood-based multi-cancer early detection (MCED) screening test in people with a high risk of cancer due to inherited gene changes or strong family history. The goal is to see if this test can find cancer early.
Boston, MassachusettsAges 22 years+ - NCT07411443Recruiting
AI breast cancer screening study for women
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
Shanghai, ShaghaiAges 35–69 - NCT05776173Recruiting
Gene-modified stem cell treatment for transfusion-dependent thalassemia
This trial tests whether giving you your own (autologous) gene-modified blood stem cells can improve transfusion-dependent beta-thalassemia and its safety. It may help people who do not have a fully matched donor and need an alternative approach to care.
ShanghaiAges 6–35 - NCT06951035Recruiting
Brain stimulation and BCI for arm movement after stroke
This study tests whether combining brain stimulation (rTMS) with a brain-computer interface (a device that reads your brain signals) can help improve arm and hand movement after a stroke. It is for people who had a single stroke more than 6 months ago and still have some weakness but can move their fingers slightly.
ParisAges 18–85 - NCT06239311RecruitingPhase 3
Methotrexate vs placebo for adults with eczema
This trial tests if methotrexate, a medication that calms the immune system, can help adults with moderate-to-severe eczema that hasn't improved with creams or other treatments. You'll either receive methotrexate or a placebo to see which works better.
Prague, Praha 1Ages 18 years+ - NCT05586724RecruitingPhase 3
Progesterone vs another hormone added to estrogen for menopause symptoms
This Phase 3 study compares two types of progesterone—micronized progesterone versus norethisterone acetate—both used with estrogen to treat menopause symptoms that affect daily life. It aims to see which combination works better and is tolerated over time for women with an intact uterus.
StockholmAges 45–60 - NCT07120633Recruiting
CAR-T cell therapy plus BTK inhibitor for high-risk CLL/SLL
This trial tests a new approach for people newly diagnosed with high-risk CLL or SLL. It combines your own immune cells (CAR-T cells) with a targeted pill (BTK inhibitor) to try to attack the cancer more effectively. It may be an option if you have certain high-risk genetic features and haven't had prior chemotherapy.
Xuzhou, JiangsuAges 18 years+ - NCT06488482RecruitingPhase 3
Short immunotherapy after melanoma surgery
This trial tests whether giving a shorter course of immunotherapy after surgery can help prevent melanoma from coming back. It is for people with high-risk melanoma who have had the cancer fully removed.
HelsinkiAges 18 years+ - NCT05865652Recruiting
7T brain scan study for teens at risk of psychosis
This trial tests how the brain’s cell membranes and energy use look in teens who are at high risk of developing psychosis. It compares them with healthy teens to better understand early brain changes that might help future care.
PoitiersAges 15–25 - NCT06879938Recruiting
Hyaluronic Acid and Oxygen Therapy for Menopause Symptoms
This trial tests a combination of a vaginal gel (hyaluronic acid) and a special oxygen device for women experiencing vaginal dryness and discomfort due to menopause, including those with a history of breast cancer. It aims to see if this treatment can improve symptoms better than standard care.
Pavia, PaviaAges 18 years+ - NCT06581432RecruitingPhase 2
Zongertinib for advanced cancers with HER2 changes
This trial tests an experimental drug (zongertinib) for people with advanced solid tumors that have certain changes in the HER2 gene. It's for those who have already tried at least one standard treatment and need more options.
Anchorage, AlaskaAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,705 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.